Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,212,301 papers from all fields of science
Search
Sign In
Create Free Account
sevirumab
Known as:
SDZ-MSL-109
, protovir
, SDZ MSL 109
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Monoclonal Antibodies
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109
A. Fouts
,
L. Comps-Agrar
,
+5 authors
B. Feierbach
Proceedings of the National Academy of Sciences
2014
Corpus ID: 508830
Significance The CMV glycoprotein (g) entry complex gH/gL is a significant target of the human immune system, eliciting…
Expand
2011
2011
Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions.
K. Manley
,
John Anderson
,
+4 authors
Adam L. Feire
Cell Host and Microbe
2011
Corpus ID: 28588668
2010
2010
MINOS neutrino oscillation results
A. Habig
2010
Corpus ID: 118661142
Neutrinos interact only weakly with other matter and had been thought to be massless. However, if their mass is non-zero, they…
Expand
Highly Cited
2009
Highly Cited
2009
Marginal Space Learning for Efficient Detection of 2D/3D Anatomical Structures in Medical Images
Yefeng Zheng
,
B. Georgescu
,
D. Comaniciu
Information Processing in Medical Imaging
2009
Corpus ID: 10161631
Recently, marginal space learning (MSL) was proposed as a generic approach for automatic detection of 3D anatomical structures in…
Expand
2006
2006
First observations of separated atmospheric nu(mu) and anti-nu(mu) events in the MINOS detector
P. Adamson
,
T. Alexopoulos
,
+249 authors
R. Zwaska
2006
Corpus ID: 548249
The complete 5.4 kton MINOS far detector has been taking data since the beginning of August 2003 at a depth of 2070 meters water…
Expand
2004
2004
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone…
M. Borucki
,
J. Spritzler
,
+13 authors
R. Pollard
Antiviral Research
2004
Corpus ID: 22281973
2002
2002
HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial
D. Jabs
,
A. Gilpin
,
Y. Min
,
A. Erice
,
J. Kempen
,
T. Quinn
AIDS (London)
2002
Corpus ID: 37624001
ObjectiveTo determine the association of cytomegalovirus (CMV) viremia with mortality and CMV retinitis progression in newly…
Expand
Highly Cited
2001
Highly Cited
2001
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell…
M. Boeckh
,
R. Bowden
,
+8 authors
J. Zaia
Biology of Blood and Marrow Transplantation
2001
Corpus ID: 28110555
Review
2000
Review
2000
Therapeutic developments in cytomegalovirus retinitis
Vonda F Hoffman
,
D. Skiest
Expert Opinion on Investigational Drugs
2000
Corpus ID: 6621431
The incidence of cytomegalovirus (CMV) retinitis in AIDS has declined significantly due to the use of highly active…
Expand
1997
1997
MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial. The Studies of Ocular…
A M A Archives of Ophthalmology
1997
Corpus ID: 1481283
OBJECTIVE To evaluate the efficacy and safety of an intravenous human monoclonal antibody to cytomegalovirus (CMV), MSL-109, as…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE